ULCA is a clinical research site located in Los Angeles, California, United States 90095.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
ULCA has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer.
Sponsors: ArriVent BioPharma, Inc..
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
ULCA has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
ULCA has 1 clinical trials on record, with 1 currently active. Their work covers Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer.
ULCA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.